Poster Abstract Session:
76. Vaccine Studies, Adjuvants, and Discovery
Friday, October 21, 2011: 12:15 PM-2:15 PM
Room: Poster Hall B1

Learning Objectives:

-

Target Audience: Academicians

Topical Category: I. Adult and Pediatric Vaccines

Tracks: Pediatric ID, Adult ID

Presentations:

713
Long-term and Cross-reactive Immunogenicity of Inactivated Trivalent Influenza Vaccine in the Elderly: MF59 Adjuvanted Vaccine Versus Unadjuvanted Vaccine
Joon Young Song, MD ; Hee Jin Cheong, MD ; Ji Yun Noh, MD ; Jung Yeon Heo, MD ; Yu Bin Seo ; In Sun Kim ; Won Suk Choi, MD ; Woo Joo Kim, MD

714
Long-Term Safety and Immunogenicity of AS03-adjuvanted or Non-adjuvanted H1N1 Vaccines in Adults and the Elderly
William Yang ; Marc Dionne ; Olivier Godeaux ; Miguel Madariaga ; Ping Li, MS ; David Vaughn

716
M2e-Flagellin Conjugate Influenza Vaccine IgG Responses in Humans
Richard Sullivan, BS ; Jeremy Rahkola, BS ; Uma Kavita, PhD ; Lynda Tussey, PhD ; David Taylor, MD ; Myron Levin, MD ; Edward Janoff, MD

717
Phase 1 Dosage Escalation, Safety and Immunogenicity Study of a Bivalent Norovirus VLP Vaccine by the Intramuscular Route
Sharon Frey, MD ; John J. Treanor, MD ; Robert L. Atmar, MD ; David Topham, PhD ; Wilbur H. Chen, MD ; Jennifer Ferreira, ScM, RAC ; Robert F. Bargatze ; Paul M. Mendelman, MD ; Charles Richardson, PhD

718
A Randomized, Multi-Center Trial to Evaluate the Safety and Immunogenicity of Staphylococcus aureus Toxoids, rAT and rLukS-PV, in Healthy Volunteers
Michael Landrum, MD ; Tahaniyat Lalani, MD ; Minoo Niknian, PhD ; Jason Maguire, MD ; Duane Hospenthal, MD, PhD ; Ali Fattom, PhD ; Kimberly Taylor, PhD ; Jamie Fraser, MPH ; Kenneth Wilkins, PhD ; Michael Ellis, MD ; Paul Kessler, MD ; Raafat Fahim, PhD ; David Tribble, MD, DrPH

720
Changing Varicella Epidemiology Since Implementation of Routine 2-Dose Varicella Vaccination for Children, Active Surveillance Areas, United States, 2006-2010
Stephanie R. Bialek, MD, MPH ; John Zhang, PhD ; Christina Jackson, MPH ; Kendra Viner, PhD, MPH ; Barbara M. Watson, MB, ChB, FRCP(UK), FAAP ; Hung Fu Tseng, Ph.D., MPH ; Adriana S Lopez, MHS ; Rachel Civen, MD, MPH ; Dana Perella, MSPH

722
Persistence of Immunity After Two-dose Inactivated Hepatitis A Vaccination of Infants and Young Children According to Maternal Antibody to Hepatitis A Virus Status: 10-year Follow-up
Umid M. Sharapov, MD, MSc ; Lisa Bulkow, MS ; Susan Negus, RN ; Philip R. Spradling, MD ; Chriss Homan, BS ; Jan Drobeniuc, MD, PhD ; Michael Bruce, MD, MPH ; Saleem Kamili, PhD ; Dale Hu, MD, MPH ; Brian McMahon, MD

723
Immunogenicity and Duration of Protection Among Hemodialysis Patients After Primary or Revaccination Series of Hepatitis B Vaccine: Implications for Defining Vaccine-Induced Immunity
Sandra Chaves, MD, MSc ; Danni Daniels, MS ; Brian Cooper, MD ; Susan Malo-Schlegel, RN CIC ; Susan MacArthur, RN CIC CPHQ MPH ; John Kobetitsch, R.N. J.D. ; Aimee McDanial, MSN RN ; John D'Avella, MD FASN ; Miriam J Alter, PhD

CME Credits:

ACPE Credits:

ACPE Number:


Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.